DYLAN IRISH: Open Payments
NPI 1134785967 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,853 in 133 payments from 24 companies in 2025. Trend: 2023 $1,716 · 2024 $1,544 · 2025 $2,853
Food & beverage: $2,753Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $404 |
| Regeneron Healthcare Solutions, Inc. | 9 | $262 |
| Janssen Biotech, Inc. | 8 | $243 |
| Novartis Pharmaceuticals Corporation | 13 | $208 |
| LEO Pharma Inc. | 11 | $175 |
| Botanix SB Inc | 8 | $171 |
| Incyte Corporation | 10 | $165 |
| Lilly USA, LLC | 2 | $153 |
| Galderma Laboratories, L.P. | 13 | $149 |
| Arcutis Biotherapeutics, Inc. | 7 | $144 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, SOFDRA, OPZELURA, RINVOQ, ADBRY, EBGLYSS.
Industry payments across AZ — which companies pay providers there.
